Basics Vir Biotechnology, Inc. IPO Date: October 11, 2019 Sector: Healthcare Industry: Biotech Market Cap: $644.19M Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 3.18% Avg Daily Range (30 D): $0.15 | 2.85% Avg Daily Range (90 D): $0.21 | 3.00% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): 1.16M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 95 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 3,007 Avg Inst. Trade: $2.49M Avg Inst. Trade (30 D): $.95M Avg Inst. Trade (90 D): $1.4M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.75M Avg Closing Trade (30 D): $.92M Avg Closing Trade (90 D): $1.49M Avg Closing Volume: 181.07K         News Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research May 24, 2024 @ 5:01 PM Evaluating Vir Biotechnology: Insights From 5 Fina... Source: Benzinga Insights May 7, 2024 @ 1:00 PM Deep Dive Into Vir Biotechnology Stock: Analyst Pe... Source: Benzinga Insights May 2, 2024 @ 10:05 PM Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Top... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.88 $-1.56 $-1.02 Diluted EPS $-.88 $-1.56 $-1.02 Revenue $ 3.03M $ 2.38M $ 3.08M Gross Profit $ $ 2.33M $ 3.02M Net Income / Loss $ -120.97M $ -213.72M $ -138.38M Operating Income / Loss $ -139.55M $ -231.3M $ -158.63M Cost of Revenue $ M $ .05M $ .05M Net Cash Flow $ 49.3M $ -52.85M $ 136.7M PE Ratio